Stock fact sheet · data as of

William Blair Emerging Mkts Growth N (WBENX): fair value, margin of safety and Wheel Score

Financial Services · Asset Management · United States · Speculative / Distressed

Close19.02
GLS fair value0.31741 of 9 models
Margin of safety-5893%price above fair value
Wheel Score18No optionscapped: no options
Health2/9Piotroski F-score
Moat3.6/10GLS 10-year score
Market cap$1.1B
Implied vol.-no listed options
P/E-EPS 0.00
Dividend yield0.11%payout 0%
Beta1.11about the market
Next earnings-no date recorded

Is WBENX undervalued?

William Blair Emerging Mkts Growth N (WBENX) closed at 19.02 on 16 Oct 2026, 5893% above the GLS average fair value of 0.3174. 1 of the 1 models that produced a number value the shares below the current price. A gap this wide usually means the market is paying for growth or a story the trailing numbers do not show yet; the models work from filed results, not forecasts, so they are conservative by design.

Only 1 of the nine models produced a value (DDM); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files WBENX under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for WBENX

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM0.3174-98%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)-0.1860-101%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: WBENX passes 2 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 3.6 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are moderate - ROIC 7.2%, ROE 7.5%, ROA 7.1% - with debt at 0.05 times equity and negative free cash flow.

The dividend yield is 0.11% with a payout ratio of 0% - a small yield that leaves most of the earnings in the business.

Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score2 / 9ROIC7.2%
GLS Moat3.6 / 10ROE7.5%
Debt / equity0.05ROA7.1%
Free-cash-flow yield0.0%Payout ratio0%
Institutions5 / 10Insiders · Congress5 · 5 / 10

Wheel Score 18: No options

WBENX has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (18 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at - a day on a market cap of $1.1B, with a beta of 1.11; the Stability part of the Wheel Score gives that 8 of 20.

PartPointsFrom
Value0 / 25-5893% margin of safety
Health4 / 20Piotroski 2/9
Moat5 / 15moat 3.6/10
Premium0 / 20no option data
Stability8 / 200k shares/day, $1.1B cap, beta 1.11

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for WBENX in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to William Blair Emerging Mkts Growth N by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
ARDVX
American Century One Choice 2040 Ptf Investor Class
14.049.66-45%18No options$1.1B
VIISX
Virtus KAR International Small-Mid Cap Fund
21.2738.36+45%39No options$1.1B
VRISX
Virtus KAR International Small-Mid Cap Fund Class R6
21.3159.89+64%39No options$1.1B
AOD
Abrdn Total Dynamic Dividend Fund
10.1663.07+84%39No options$1.1B
ARCVX
American Century Investments One Choice 2030 Portfolio
12.798.52-50%18No options$1.1B
OCSL
Oaktree Specialty Lending Corporation
11.7824.83+53%68Good$1.0B
FSCO
FS Credit Opportunities Corp.
5.1329.89+83%39No options$1.0B
AOCIX
American Century One Choice Portfolio: Conservative Investor Class
14.003.98-252%18No options$1.0B
BAQAX
Brown Advisory Emerging Markets Select Fund Advisor Shares
16.692.92-472%18No options$1.0B
WBSNX
William Blair Small Cap Growth Fund Class N
29.8019.51-53%20No options$1.1B
HQH
Abrdn Healthcare Investors
19.3051.65+63%39No options$1.1B
BTX
BlackRock Technology and Private Equity Term Trust
8.6853.23+84%39No options$1.0B

⚖ Compare WBENX with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about WBENX

Is WBENX undervalued right now?

No: at 19.02 the stock trades 5893% above the GLS average fair value of 0.3174 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of WBENX and what does it mean?

WBENX has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for WBENX?

0.3174 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does William Blair Emerging Mkts Growth N report earnings next?

No upcoming earnings date is recorded for WBENX in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does WBENX have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on WBENX, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.